You are here

Japan drugmakers feeling the heat from copycats

Many emerging nations fail to protect IP rights


JAPAN's pharmaceutical companies are struggling to do business in emerging nations due to the proliferation of copycat drugs, with a Chinese firm allegedly making a drug for Ebola that Fujifilm Holdings Corp says infringes on its intellectual property rights.

Fujifilm plans

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom